Aimei Health Technology Statistics
Total Valuation
AFJK has a market cap or net worth of $254.66 million. The enterprise value is $256.69 million.
Important Dates
The last earnings date was Monday, May 4, 2026, after market close.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AFJK has 6.12 million shares outstanding.
| Current Share Class | 6.12M |
| Shares Outstanding | 6.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.18% |
| Owned by Institutions (%) | 16.03% |
| Float | 4.40M |
Valuation Ratios
The trailing PE ratio is 240.30.
| PE Ratio | 240.30 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 242.21 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.22% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -9.57% |
| Weighted Average Cost of Capital (WACC) | 6.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +273.09% in the last 52 weeks. The beta is 0.46, so AFJK's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +273.09% |
| 50-Day Moving Average | 37.46 |
| 200-Day Moving Average | 28.28 |
| Relative Strength Index (RSI) | 49.14 |
| Average Volume (20 Days) | 6,348 |
Short Selling Information
The latest short interest is 5,686, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 5,686 |
| Short Previous Month | 7,388 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 0.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -835,759 |
| Pretax Income | 1.06M |
| Net Income | 1.06M |
| EBITDA | n/a |
| EBIT | -835,759 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $2,929 in cash and $2.02 million in debt, with a net cash position of -$2.02 million or -$0.33 per share.
| Cash & Cash Equivalents | 2,929 |
| Total Debt | 2.02M |
| Net Cash | -2.02M |
| Net Cash Per Share | -$0.33 |
| Equity (Book Value) | -4.06M |
| Book Value Per Share | n/a |
| Working Capital | -3.37M |
Cash Flow
| Operating Cash Flow | -565,100 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 2.29M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
